0000000000911263

AUTHOR

Leandro Machado

showing 2 related works from this author

Effects of alirocumab on types of myocardial infarction : insights from the ODYSSEY OUTCOMES trial

2019

Gislason, Gunnar H/0000-0002-0548-402X; Malynovsky, Yaroslav V/0000-0002-9118-1104; Bhatt, Deepak L./0000-0002-1278-6245; Nikolaev, Konstantin/0000-0003-4601-6203; Sherwood, Matthew/0000-0002-4305-5883; Chumakova, Galina A/0000-0002-2810-6531; Raffel, Owen C/0000-0001-5470-7050; Leonardi, Sergio/0000-0002-4800-6132; Tse, Hung Fat/0000-0002-9578-7808; Reshetko, Olga/0000-0003-3107-7636; Pereira, Helder/0000-0001-8656-4883; Racca, Vittorio/0000-0002-4465-3789; Podoleanu, Cristian/0000-0001-9987-2519; Ersanli, Murat/0000-0003-1847-3087; Muenzel, Thomas/0000-0001-5503-4150; Sandhu, Manjinder/0000-0003-2538-2079; Taskinen, Marja-Riitta/0000-0002-6229-3588; bastos, jose/0000-0002-9526-3123; Manak…

MaleBIOMEDICINE AND HEALTHCARE. Clinical Medical Sciences.Cardiac & Cardiovascular SystemsMyocardial InfarctionUNIVERSAL DEFINITION030204 cardiovascular system & hematologyTHERAPYDISEASEchemistry.chemical_compound0302 clinical medicineCardiac and Cardiovascular Systems030212 general & internal medicineMyocardial infarctionProspective Studies1102 Cardiorespiratory Medicine and HaematologyOxygen supplyKardiologiBIOMEDICINA I ZDRAVSTVO. Kliničke medicinske znanosti.CHOLESTEROLMiddle AgedMI typesCardiologyLDL Cholesterol LipoproteinsFemaleCardiology and Cardiovascular MedicineLife Sciences & Biomedicinemedicine.medical_specialty610ODYSSEY OUTCOMES InvestigatorsAntibodies Monoclonal HumanizedCLASSIFICATION03 medical and health sciencesDouble-Blind MethodInternal medicinemedicineHumansddc:610Alirocumab ; MI types ; Mortality ; PreventionMortalityMETAANALYSISAlirocumabAgedScience & TechnologyTask forceCholesterolbusiness.industryEVOLOCUMABPrevention1103 Clinical SciencesCholesterol LDLmedicine.diseaseEvolocumabchemistryCardiovascular System & HematologyCardiovascular System & CardiologyHuman medicinebusinessAlirocumab
researchProduct

Oxygen uptake kinetics and energy system's contribution around maximal lactate steady state swimming intensity

2017

Made available in DSpace on 2018-11-26T17:20:55Z (GMT). No. of bitstreams: 0 Previous issue date: 2017-02-28 Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) Ministry of Education of Brazil The purpose of this study was to examine the oxygen uptake ((V) over dotO(2)) kinetics and the energy systems' contribution at 97.5, 100 and 102.5% of the maximal lactate steady state (MLSS) swimming intensity. Ten elite female swimmers performed three-to-five 30 min submaximal constant swimming bouts at imposed paces for the determination of the swimming velocity (v) at 100% MLSS based on a 7 x 200 m intermittent incremental protocol until voluntary exhaustion to find the v associated…

Time FactorsAnaerobic ThresholdPhysiologyVelocitylcsh:MedicinePathology and Laboratory MedicineOxygenBiochemistryOxygen uptake kinetics0302 clinical medicineMedicine and Health SciencesPublic and Occupational Healthlcsh:ScienceFatigueMultidisciplinaryChemistryPhysicsTime constantClassical Mechanics16. Peace & justiceSports ScienceBody FluidsChemistryvVO2maxBloodPhysical SciencesLactatesFemaleAnatomyAnaerobic exerciseResearch ArticleChemical ElementsSportsAdolescentchemistry.chemical_elementBioenergetics03 medical and health sciencesYoung AdultMotionAnimal scienceOxygen ConsumptionSigns and SymptomsDiagnostic MedicineHumansLactic AcidSports and Exercise MedicineEnergy systemExerciseSwimmingBehaviorBiological Locomotionlcsh:RBiology and Life Sciences030229 sport sciencesPhysical ActivityIntensity (physics)OxygenKineticsAthletesPhysical FitnessExercise TestPhysical EnduranceRecreationlcsh:QSteady state (chemistry)Energy Metabolism030217 neurology & neurosurgery
researchProduct